ReviewFrontiers in oncology2021

Combination of Immune Checkpoint Inhibitors and Anti-Angiogenic Agents in Brain Metastases From Non-Small Cell Lung Cancer.

Likui Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.